%0 Journal Article
%T Discovery of novel chrysin derivatives as potential Anti-Psoriasis agents.
%A Zhao X
%A Du C
%A Zeng Y
%A Chen Y
%A Xu J
%A Yin X
%A Hu C
%A Mao Z
%A Lin Y
%J Bioorg Chem
%V 150
%N 0
%D 2024 Jun 27
%M 38955004
%F 5.307
%R 10.1016/j.bioorg.2024.107599
%X Psoriasis is a chronic inflammatory disease and is difficult to cure. In this work, a series of novel chrysin derivatives have been designed and prepared while evaluating anti-inflammatory activities in vitro and in vivo. In vitro, RAW264.7 cells were used to detect the inflammatory activities at first, and compounds 4h, 4k, and 4o significantly decreased the levels of NO, TNF-α, and IL-6. In particular, compound 4o showed superior anti-inflammatory activities than other compounds. Moreover, compound 4o decreased the level of IL-17A in LPS-induced HaCaT cells in vitro. The effect and mechanism of anti-inflammatory activities on psoriasis were determined by imiquimod (IMQ)-induced psoriasis-like mice in vivo. Compound 4o deduced the level of IL-6, IL-17A, IL-22, IL-23, and TNF-α, and showed potent anti-psoriasis activity. Further mechanism study suggested that compound 4o could improve the skin inflammation of psoriasis by inhibiting the NF-κB and STAT3 signaling pathways.